328 related articles for article (PubMed ID: 19564547)
1. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
Chang SA; Kim YJ; Lee HW; Kim DH; Kim HK; Chang HJ; Sohn DW; Oh BH; Park YB
Hypertension; 2009 Sep; 54(3):591-7. PubMed ID: 19564547
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.
Gómez-Garre D; González-Rubio ML; Muñoz-Pacheco P; Caro-Vadillo A; Aragoncillo P; Fernández-Cruz A
Eur J Heart Fail; 2010 Sep; 12(9):903-12. PubMed ID: 20601374
[TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat.
Loch D; Chan V; Hoey A; Brown L
Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):262-70. PubMed ID: 19583711
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Loch D; Levick S; Hoey A; Brown L
J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082
[TBL] [Abstract][Full Text] [Related]
6. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats.
Akahori H; Tsujino T; Naito Y; Matsumoto M; Sasaki N; Iwasaku T; Eguchi A; Sawada H; Hirotani S; Masuyama T
J Hypertens; 2014 Jul; 32(7):1534-41; discussion 1541. PubMed ID: 24759122
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
Habibi J; Whaley-Connell A; Qazi MA; Hayden MR; Cooper SA; Tramontano A; Thyfault J; Stump C; Ferrario C; Muniyappa R; Sowers JR
Endocrinology; 2007 May; 148(5):2181-8. PubMed ID: 17317778
[TBL] [Abstract][Full Text] [Related]
9. Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction.
Klotz S; Hay I; Zhang G; Maurer M; Wang J; Burkhoff D
Hypertension; 2006 May; 47(5):901-11. PubMed ID: 16585423
[TBL] [Abstract][Full Text] [Related]
10. Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.
Yamamoto M; Ishizu T; Seo Y; Suto Y; Sai S; Xu D; Murakoshi N; Kimura T; Kawakami Y; Aonuma K
J Card Fail; 2018 Jan; 24(1):53-60. PubMed ID: 28888840
[TBL] [Abstract][Full Text] [Related]
11. [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].
Sicard P; Lauzier B; Oudot A; Busseuil D; Collin B; Duvillard L; Moreau D; Vergely C; Rochette L
Arch Mal Coeur Vaiss; 2005; 98(7-8):804-8. PubMed ID: 16220751
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
[TBL] [Abstract][Full Text] [Related]
13. Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart.
Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Hori M
J Hypertens; 2002 Apr; 20(4):753-61. PubMed ID: 11910313
[TBL] [Abstract][Full Text] [Related]
14. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
Horinaka S; Kobayashi N; Yagi H; Mori Y; Matsuoka H
J Cardiovasc Pharmacol; 2006 May; 47(5):629-35. PubMed ID: 16775500
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease.
Ishizu T; Seo Y; Kameda Y; Kawamura R; Kimura T; Shimojo N; Xu D; Murakoshi N; Aonuma K
Hypertension; 2014 Mar; 63(3):500-6. PubMed ID: 24396022
[TBL] [Abstract][Full Text] [Related]
16. [Sympathetic nerve in rat with pressure overload left ventricular hypertrophy].
Liao Y; Qu XF; Liu L; Dong XM; Yin DC
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2412-5. PubMed ID: 20137696
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats.
Sakata Y; Masuyama T; Yamamoto K; Nishikawa N; Yamamoto H; Kondo H; Ono K; Otsu K; Kuzuya T; Miwa T; Takeda H; Miyamoto E; Hori M
Circulation; 2000 Oct; 102(18):2269-75. PubMed ID: 11056104
[TBL] [Abstract][Full Text] [Related]
18. Macrophages dictate the progression and manifestation of hypertensive heart disease.
Kain D; Amit U; Yagil C; Landa N; Naftali-Shani N; Molotski N; Aviv V; Feinberg MS; Goitein O; Kushnir T; Konen E; Epstein FH; Yagil Y; Leor J
Int J Cardiol; 2016 Jan; 203():381-95. PubMed ID: 26539962
[TBL] [Abstract][Full Text] [Related]
19. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
20. Exercise training alters left ventricular geometry and attenuates heart failure in dahl salt-sensitive hypertensive rats.
Miyachi M; Yazawa H; Furukawa M; Tsuboi K; Ohtake M; Nishizawa T; Hashimoto K; Yokoi T; Kojima T; Murate T; Yokota M; Murohara T; Koike Y; Nagata K
Hypertension; 2009 Apr; 53(4):701-7. PubMed ID: 19255362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
